Ying‐Ming Jou

1.0k citations
21 papers · 574 indexed · h-index 9
Topics
Multiple Myeloma Research and Treatments (13 papers)Peptidase Inhibition and Analysis (7 papers)Advanced Breast Cancer Therapies (5 papers)

In The Last Decade

Ying‐Ming Jou

21 papers receiving 561 citations

Peers

Ying‐Ming Jou
Comparison fields: 5 of 48
  • Oncology 385
  • Hematology 317
  • Molecular Biology 296
  • Pulmonary and Respiratory Medicine 112
  • Immunology 73
Replace Marielle Chiron with:
Marielle Chiron France
Jennifer Macaluso United States
Karl Hsu United States
P. Dieringer United States
Paolo Ditonno Italy
James Berenson United States
Norbert Grząśko Poland
Matthew S. Zabriskie United States
Timothy N. Trotter United States
Krista Fager United States
Ying‐Ming Jou relative to Marielle Chiron France Marielle Chiron's profile →
Citations per field
00.5×2.6×
Marielle Chiron · 1×
Citations per year

Countries citing papers authored by Ying‐Ming Jou

Since Specialization
Citations

This map shows the geographic impact of Ying‐Ming Jou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Ming Jou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Ming Jou more than expected).

Fields of papers citing papers by Ying‐Ming Jou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Ming Jou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Ming Jou. The network helps show where Ying‐Ming Jou may publish in the future.

Co-authorship network of co-authors of Ying‐Ming Jou

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Ming Jou. A scholar is included among the top collaborators of Ying‐Ming Jou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Ming Jou. Ying‐Ming Jou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 6
5 64
6 5
7 5
8 6
9 11
10 4
11 30
12 5
13 186
14 24
15 16
16 15
17 105
18 81
19 1
20 1

About Ying‐Ming Jou

Ying‐Ming Jou is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 574 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Peptidase Inhibition and Analysis (7 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Hematology (317 citations), Oncology (385 citations) and Genetics (61 citations). Ying‐Ming Jou has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Rajat Bannerji, Yali Zhu, Paul Statkevich, Da Zhang, Siu‐Long Yao, John Nemunaitis, Karen Small, Mark Lynch, Jacob P. Laubach and Michael Robbins. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026